Radforsk Investment Foundation has granted five research projects a total amount of NOK 4,95 million to further develop exciting research projects within photodynamic treatment and photochemical internalization. Cancer researcher Pål Selbo receives NOK 3,75 million for his project. Radforsk Investment Foundation is an evergreen investor focusing on companies that develop cancer treatment. “Radforsk has invested […]
Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
We participated in the influential technology conference SXSW2021.
OCC Accelerator will help start-ups in cancer innovation succeed.
Putting a spotlight on equality in cancer research